Sunday, July 26th — An excerpt from a long article by Michael Chossoduvsky, dated 7/27/09.
Forced Vaccination under a Public Health Emergency? Multibillion Financial Bonanza for the BioTech Conglomerates
The 2005 bird flu hoax was in many regards a dress rehearsal. The 2009 H1N1 pandemic is a much larger multibillion dollar operation. A select number of biotech and pharmaceutical companies have been involved in negotiations behind closed doors with the WHO and the US Administration. Key agencies are the Atlanta based Center for Disease Control and the Food and Drug Administration (FDA) which have close ties to the pharmaceutical industry. The conflicts of interest of these agencies is brought to light in Robert F. Kennedy Jr.’s detailed study entitled Vaccinations: Deadly Immunity, June 2005:
“The story of how government health agencies colluded with Big Pharma to hide the risks of thimerosal from the public is a chilling case study of institutional arrogance, power and greed. I was drawn into the controversy only reluctantly. As an attorney and environmentalist who has spent years working on issues of mercury toxicity, I frequently met mothers of autistic children who were absolutely convinced that their kids had been injured by vaccines. … “The elementary grades are overwhelmed with children who have symptoms of neurological or immune-system damage,” Patti White, a school nurse, told the House Government Reform Committee in 1999. “Vaccines are supposed to be making us healthier; however, in twenty-five years of nursing I have never seen so many damaged, sick kids. Something very, very wrong is happening to our children.” Robert F. Kennedy Jr, Vaccinations: Deadly Immunity, June 2005.
The WHO is planning for the production of 4.9 billion dose, enough to inoculate a large share of the World’s population. Big Pharma including Baxter, GlaxoSmithKline, Novartis, Sanofi-Aventis and AstraZeneca have signed procurement contracts with some 50 governments. (Reuters, July 16, 2009). For these companies, compulsory vaccination is a highly lucrative undertaking:
“The WHO has refused to release the Minutes of a key meeting of an advisory vaccine group “packed with executives from Baxter, Novartis and Sanofi” that recommended compulsory vaccinations in the USA, Europe and other countries against the artificial H1N1 “swine flu” virus this autumn.
In an email this morning, a WHO spokesperson claimed there are no Minutes of the meeting that took place on July 7th in which guidelines on the need for worldwide vaccinations that WH0 adopted this Monday were formulated and in which Baxter and other Pharma executives participated.
Under the International Health Regulations, WHO guidelines have a binding character on all of WHO’s 194 signatory countries in the event of a pandemic emergency of the kind anticipated this autumn when the second more lethal wave of the H1N1 virus “which is bioengineered to resemble the Spanish flu virus” emerges.
In short: WHO has the authority to force everyone in those 194 countries to take a vaccine this fall at gunpoint, impose quarantines and restrict travel.” (Jane Burgermeister, WHO moves forward in secrecy to accomplish forced vaccination and population agenda, Global Research, July 2009).
On May 19th, the WHO Director General and senior officials met behind closed doors with the representatives of some 30 pharmaceutical companies.
“In a perfect world the planet’s leading pharmaceutical companies could produce 4.9 billion H1N1 swine flu vaccinations over the course of the next year. This is the World Health Organization’s latest assessment. WHO Director-General Dr. Margaret Chan met with 30 pharmaceutical companies on Tuesday and briefed reporters on a WHO plan to secure vaccinations for poor countries who lack sufficient infrastructure to fight a possible pandemic. (Digital Journal, 19 May 2009)
According to recent report in Business Week, “Wealthier countries such as the U.S. and Britain will pay just under $10 per dose, the same price for the seasonal flu vaccine. Developing countries will pay a lower price, (Business Week, July 2009). The WHO suggests that the 4.9 billion doses will not suffice and that a second inoculation will be required.
4,9 billion doses at about ten dollars ($10.00) a shot and somewhat less in the developing countries, represents a windfall profit bonanza for Big Pharma of the order of 400 billion dollars in a single year. And the WHO claims that one dose per person may not suffice…
See more here:
Click Below to:
John Haines is the author of In Search of Simplicity: A True Story that Changes Lives.